Kavar Capital Partners Group’s Avanos Medical AVNS Stock Holding History

Kavar Capital Partners Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-18	Closed	-$1K	–	119
2018 Q2	$1K	Hold	18	–	–	﹤0.01%	425
2018 Q1	$1K	Buy	+18	New	+$855	﹤0.01%	418
2016 Q1	–	Sell	-18	Closed	–	–	117
2015 Q4	$0	Hold	18	–	–	﹤0.01%	480
2015 Q3	$0	Hold	18	–	–	﹤0.01%	481
2015 Q2	$0	Buy	+18	New	+$808	﹤0.01%	514

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Kavar Capital Partners Group's AVNS Position: Q3 2018 in Review

Kavar Capital Partners Group sold out of Avanos Medical (AVNS) in Q3 2018, closing a stake of 18 shares — an estimated $1K sold.

Kavar Capital Partners Group first reported a position in AVNS in Q2 2015 and held it in 5 quarters. The position peaked at $1K in Q2 2018. 387 funds tracked by Wall St. Rank hold AVNS as of Q3 2018.

Kavar Capital Partners Group reported no remaining Avanos Medical position as of Q3 2018 after selling out during the quarter.
Kavar Capital Partners Group sold 18 Avanos Medical shares in Q3 2018, an estimated $1K.
Kavar Capital Partners Group first reported a position in Avanos Medical in Q2 2015 and held it in 5 quarters.
Kavar Capital Partners Group's Avanos Medical position peaked at $1K in Q2 2018.
387 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2018.

Based on Kavar Capital Partners Group's 13F filing for Q3 2018, filed 9 Nov 2018.